CIK 0001069530 · Non-accelerated filer<br>Smaller reporting company
FILANA THERAPEUTICS, INC.
Sign in to watch- Ticker
- FLNA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 911911336
- Phone
- 512-501-2444
- Business address
- 6801 N CAPITAL OF TEXAS HIGHWAY, BUILDING 1; SUITE 300, AUSTIN, TX, 78731
- Former names
- CASSAVA SCIENCES INC, PAIN THERAPEUTICS INC
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 8-K Event Executive or director change · Regulation FD disclosure
- ARS Other Annual Report to Security Holders
- DEF 14A Proxy Proxy Statement
- PRE 14A Proxy Proxy Statement (Preliminary)
- 8-K Event Regulation FD disclosure · Other events
- 8-K Event Executive or director change
- 10-K Report Annual Report
- 8-K Event Results of operations
- 8-K Event Material agreement · Regulation FD disclosure
- 8-K Event Results of operations · Exit or restructuring costs · Other events
- 4 Open-market sale Chief Medical Officer sold 4,000 shares at $3.87 ($15,480)
- 4 Open-market sale Chief Financial Officer sold 61,800 shares at an average $3.86 ($238,468)
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- 8-K Event Other events
- 4 Derivatives Options or other derivatives
Page 4 of 62 · 1,225 filings